Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,733 | 2,705 | 3,394 | 3,203 | 3,570 |
| Operating Income | -2,733 | -2,705 | -3,394 | -3,203 | -3,570 |
| Other Income | 62 | 168 | 47 | 22 | 57 |
| Pre-tax Income | -2,671 | -2,537 | -3,347 | -3,181 | -3,513 |
| Net Income Continuous | -2,671 | -2,537 | -3,347 | -3,181 | -3,513 |
| Net Income | $-2,671 | $-2,537 | $-3,347 | $-3,181 | $-3,513 |
| EPS Basic Total Ops | -0.06 | -0.13 | -0.22 | -0.22 | -0.25 |
| EPS Basic Continuous Ops | -0.06 | -0.13 | -0.22 | -0.22 | -0.25 |
| EPS Diluted Total Ops | -0.06 | -0.13 | -0.22 | -0.22 | -0.25 |
| EPS Diluted Continuous Ops | -0.06 | -0.13 | -0.22 | -0.22 | -0.25 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.13 | -0.22 | -0.22 | -0.25 |
| EBITDA(a) | $-2,727 | $-2,698 | $-3,388 | $-3,197 | $-3,563 |